RankAlpha logo
Back to Rankings

BCAX

Bicara TherapeuticsA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
Above peers
vs peer average
BCAX vs peer average
88/100
BCAX vs. peer average (A vs. C)
Grade spread
A 2 · C 1 · D 3 · F 2
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

ABSI is the first available peer comparator.

Loose same-sector market-cap biotechnology comp; modality and clinical programs differ materially, so it is more useful for sentiment and risk comparison than valuation.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerABSIAbsci
BCAX
Bicara Therapeutics
ABSI
Absci
Grade
A
F
Momentum
55
72
Value
46
41
Sentiment
82
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs ABSI

BCAX / ABSI
Grade Position
Above peers
BCAX vs. peer average (A vs. C)
88/100
Momentum
55
ABSI
Value
46
BCAX
Sentiment
82
BCAX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BCAX
1
ABSI
ABSI
F
20/100
+4
2
MAZE
MAZE
D
40/100
+3
3
TRAX
First Tracks Biotherapeutics Inc Common
N/A
-
-
4
AVLN
Avalyn Pharma Inc Common
C
60/100
+2
5
FBRX
Forte Biosciences Inc Common
F
20/100
+4
ABSI is the first peer returned for this comparison set.